Report cover image

Global Skin Topical Medications Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 194 Pages
SKU # APRC20278891

Description

Summary

According to APO Research, the global Skin Topical Medications market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Skin Topical Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Skin Topical Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Skin Topical Medications market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Skin Topical Medications is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Skin Topical Medications market include Regeneron, Shanghai Xiao Fang Pharmaceutical, Teva, Sandoz, Mylan, Pfizer, Novartis, LEO Pharma and Johnson & Johnson, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Skin Topical Medications, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Skin Topical Medications, also provides the value of main regions and countries. Of the upcoming market potential for Skin Topical Medications, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Skin Topical Medications revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Skin Topical Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Skin Topical Medications company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.

Skin Topical Medications Segment by Company


Regeneron

Shanghai Xiao Fang Pharmaceutical

Teva

Sandoz

Mylan

Pfizer

Novartis

LEO Pharma

Johnson & Johnson

GlaxoSmithKline

Galderma

Celgene

Allergan

AbbVie

Skin Topical Medications Segment by Type


Antibacterial Agent

Antifungal Agent

Emollient

Others

Skin Topical Medications Segment by Application


For Youth

For the Elderly

For Children

Skin Topical Medications Segment by Region


North America


United States

Canada

Mexico

Europe


Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific


China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America


Brazil

Argentina

Chile

Middle East & Africa


Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Skin Topical Medications status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Skin Topical Medications key companies, revenue, market share, and recent developments.
3. To split the Skin Topical Medications breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Skin Topical Medications market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Skin Topical Medications significant trends, drivers, influence factors in global and regions.
6. To analyze Skin Topical Medications competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Topical Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Skin Topical Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Topical Medications.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Skin Topical Medications industry.
Chapter 3: Detailed analysis of Skin Topical Medications company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Skin Topical Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Skin Topical Medications in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Skin Topical Medications Market Size, 2020 VS 2024 VS 2031
1.3 Global Skin Topical Medications Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Skin Topical Medications Market Dynamics
2.1 Skin Topical Medications Industry Trends
2.2 Skin Topical Medications Industry Drivers
2.3 Skin Topical Medications Industry Opportunities and Challenges
2.4 Skin Topical Medications Industry Restraints
3 Skin Topical Medications Market by Company
3.1 Global Skin Topical Medications Company Revenue Ranking in 2024
3.2 Global Skin Topical Medications Revenue by Company (2020-2025)
3.3 Global Skin Topical Medications Company Ranking (2023-2025)
3.4 Global Skin Topical Medications Company Manufacturing Base and Headquarters
3.5 Global Skin Topical Medications Company Product Type and Application
3.6 Global Skin Topical Medications Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Skin Topical Medications Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Skin Topical Medications Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Skin Topical Medications Market by Type
4.1 Skin Topical Medications Type Introduction
4.1.1 Antibacterial Agent
4.1.2 Antifungal Agent
4.1.3 Emollient
4.1.4 Others
4.2 Global Skin Topical Medications Sales Value by Type
4.2.1 Global Skin Topical Medications Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Skin Topical Medications Sales Value by Type (2020-2031)
4.2.3 Global Skin Topical Medications Sales Value Share by Type (2020-2031)
5 Skin Topical Medications Market by Application
5.1 Skin Topical Medications Application Introduction
5.1.1 For Youth
5.1.2 For the Elderly
5.1.3 For Children
5.2 Global Skin Topical Medications Sales Value by Application
5.2.1 Global Skin Topical Medications Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Skin Topical Medications Sales Value by Application (2020-2031)
5.2.3 Global Skin Topical Medications Sales Value Share by Application (2020-2031)
6 Skin Topical Medications Regional Value Analysis
6.1 Global Skin Topical Medications Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Skin Topical Medications Sales Value by Region (2020-2031)
6.2.1 Global Skin Topical Medications Sales Value by Region: 2020-2025
6.2.2 Global Skin Topical Medications Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Skin Topical Medications Sales Value (2020-2031)
6.3.2 North America Skin Topical Medications Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Skin Topical Medications Sales Value (2020-2031)
6.4.2 Europe Skin Topical Medications Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Skin Topical Medications Sales Value (2020-2031)
6.5.2 Asia-Pacific Skin Topical Medications Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Skin Topical Medications Sales Value (2020-2031)
6.6.2 South America Skin Topical Medications Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Skin Topical Medications Sales Value (2020-2031)
6.7.2 Middle East & Africa Skin Topical Medications Sales Value Share by Country, 2024 VS 2031
7 Skin Topical Medications Country-level Value Analysis
7.1 Global Skin Topical Medications Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Skin Topical Medications Sales Value by Country (2020-2031)
7.2.1 Global Skin Topical Medications Sales Value by Country (2020-2025)
7.2.2 Global Skin Topical Medications Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.3.2 USA Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.4.2 Canada Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.6.2 Germany Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.7.2 France Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.7.3 France Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.9.2 Italy Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.10.2 Spain Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.11.2 Russia Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.14.2 China Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.14.3 China Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.15.2 Japan Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.17.2 India Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.17.3 India Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.18.2 Australia Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.22.2 Chile Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.24.2 Peru Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.26.2 Israel Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.27.2 UAE Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.29.2 Iran Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Skin Topical Medications Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Skin Topical Medications Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Skin Topical Medications Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Regeneron
8.1.1 Regeneron Comapny Information
8.1.2 Regeneron Business Overview
8.1.3 Regeneron Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.1.4 Regeneron Skin Topical Medications Product Portfolio
8.1.5 Regeneron Recent Developments
8.2 Shanghai Xiao Fang Pharmaceutical
8.2.1 Shanghai Xiao Fang Pharmaceutical Comapny Information
8.2.2 Shanghai Xiao Fang Pharmaceutical Business Overview
8.2.3 Shanghai Xiao Fang Pharmaceutical Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.2.4 Shanghai Xiao Fang Pharmaceutical Skin Topical Medications Product Portfolio
8.2.5 Shanghai Xiao Fang Pharmaceutical Recent Developments
8.3 Teva
8.3.1 Teva Comapny Information
8.3.2 Teva Business Overview
8.3.3 Teva Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.3.4 Teva Skin Topical Medications Product Portfolio
8.3.5 Teva Recent Developments
8.4 Sandoz
8.4.1 Sandoz Comapny Information
8.4.2 Sandoz Business Overview
8.4.3 Sandoz Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.4.4 Sandoz Skin Topical Medications Product Portfolio
8.4.5 Sandoz Recent Developments
8.5 Mylan
8.5.1 Mylan Comapny Information
8.5.2 Mylan Business Overview
8.5.3 Mylan Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.5.4 Mylan Skin Topical Medications Product Portfolio
8.5.5 Mylan Recent Developments
8.6 Pfizer
8.6.1 Pfizer Comapny Information
8.6.2 Pfizer Business Overview
8.6.3 Pfizer Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.6.4 Pfizer Skin Topical Medications Product Portfolio
8.6.5 Pfizer Recent Developments
8.7 Novartis
8.7.1 Novartis Comapny Information
8.7.2 Novartis Business Overview
8.7.3 Novartis Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.7.4 Novartis Skin Topical Medications Product Portfolio
8.7.5 Novartis Recent Developments
8.8 LEO Pharma
8.8.1 LEO Pharma Comapny Information
8.8.2 LEO Pharma Business Overview
8.8.3 LEO Pharma Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.8.4 LEO Pharma Skin Topical Medications Product Portfolio
8.8.5 LEO Pharma Recent Developments
8.9 Johnson & Johnson
8.9.1 Johnson & Johnson Comapny Information
8.9.2 Johnson & Johnson Business Overview
8.9.3 Johnson & Johnson Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.9.4 Johnson & Johnson Skin Topical Medications Product Portfolio
8.9.5 Johnson & Johnson Recent Developments
8.10 GlaxoSmithKline
8.10.1 GlaxoSmithKline Comapny Information
8.10.2 GlaxoSmithKline Business Overview
8.10.3 GlaxoSmithKline Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.10.4 GlaxoSmithKline Skin Topical Medications Product Portfolio
8.10.5 GlaxoSmithKline Recent Developments
8.11 Galderma
8.11.1 Galderma Comapny Information
8.11.2 Galderma Business Overview
8.11.3 Galderma Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.11.4 Galderma Skin Topical Medications Product Portfolio
8.11.5 Galderma Recent Developments
8.12 Celgene
8.12.1 Celgene Comapny Information
8.12.2 Celgene Business Overview
8.12.3 Celgene Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.12.4 Celgene Skin Topical Medications Product Portfolio
8.12.5 Celgene Recent Developments
8.13 Allergan
8.13.1 Allergan Comapny Information
8.13.2 Allergan Business Overview
8.13.3 Allergan Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.13.4 Allergan Skin Topical Medications Product Portfolio
8.13.5 Allergan Recent Developments
8.14 AbbVie
8.14.1 AbbVie Comapny Information
8.14.2 AbbVie Business Overview
8.14.3 AbbVie Skin Topical Medications Revenue and Gross Margin (2020-2025)
8.14.4 AbbVie Skin Topical Medications Product Portfolio
8.14.5 AbbVie Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.